The therapeutic potential of human umbilical cord blood transplantation for neonatal hypoxic-ischemic brain injury and ischemic stroke

Acta Medica Okayama

Volumn 66, Issue 6, 2012, Pages 429-434

  Wang, Feifei ^a,b   Maeda, Nagamasa ^b   Yasuhara, Takao ^a   Kameda, Masahiro ^a   Tsuru, Emi ^b   Yamashit, Tatsuyuki ^b   Shen, Yuan ^b   Tsuda, Masayuki ^b   Date, Isao ^a   Sagara, Yusuke ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Cell transplantation; Ischemic stroke; Neonatal hypoxic ischemic brain injury; Stem cells; Umbilical cord blood

Indexed keywords

ANIMAL; CEREBROVASCULAR ACCIDENT; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODEL; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; METHODOLOGY; NEWBORN; REVIEW;

ANIMALS; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; STROKE;

EID: 84873723840     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, Ciocci G, Carrier C, Stevens CE and Rubinstein P: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med (1996) 335 157-166.
2. Gluckman E, RochaV, Boyer-Chammard A, Locatelli F, Arcese W. Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP Fernandez M and Chastang C: Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med (1997) 337: 373-381.
3. Harris DT, Badowski M, Ahmad N and Gaballa MA: The potential of cord blood stem cells for use in regenerative medicine. Expert Opin Biol Ther (2007) 7: 1311-1322.
4. Herranz AS, Gonzalo-Gobernado R, Reimers D, Asensio MJ Rodriguez-Serrano M and Bazan E: Applications of human umbilical cord blood cells in central nervous system regeneration. Curr Stem Cell Res Ther (2010) 5: 17-22.
5. Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J. English D, Arny M, Thomas L and Boyse EA: Human umbilical cord blood as a potential source of transplantable hematopoietic.
6. Bieback K, Kern S, Kluter H and Eichler H: Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells (2004) 22: 625-634.
7. Hussain I, Magd SA, Eremin O and El-Sheemy M: New approach to isolate mesenchymal stem cell (MSC) from human umbilical cord blood. Cell Biol Int (2012) 36: 595-600.
8. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H Onitsuka I, Matsui K and Imaizumi T: Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascular-ization. J Clin Invest (2000) 105: 1527-1536.
9. Sun HP, Zhang X, Chen XH, Zhang C, Gao L, Feng YM, Peng XG and Gao L: Human umbilical cord blood-derived stromal cells are superior to human umbilical cord blood-derived mesenchymal stem cells in inducing myeloid lineage differentiation in vitro. Stem Cells Dev (2012) 21: 1429-1440.
10. Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO and Wall DA: Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant (2001) 7: 581-588.
11. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N Liedtke S, Sorg RV, Fischer J, Rosenbaum C, Greschat S. Knipper A, Bender J, Degistirici O, Gao J, Caplan AI, Colletti EJ Almeida-Porada G, Muller HW, Zanjani E and Wernet P: A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med (2004) 200: 123-135.
12. Seo KW, Lee SR, Bhandari DR, Roh KH, Park SB, So AY, Jung JW, Seo MS, Kang SK, Lee YS and Kang KS: OCT4A contributes to the sternness and multi-potency of human umbilical cord blood-derived multipotent stem cells (hUCB-MSCs). Biochem Biophys Res Commun (2009) 384: 120-125.
13. Lai MC, YangSN: Perinatal hypoxic-ischemic encephalopathy. J Biomed Biotechnol (2011) Epub2011Dec13.
14. LEVINE S: Anoxic-ischemic encephalopathy in rats. Am J Pathol (1960)36: 1-17.
15. Rice JE 3rd, Vannucci RC and Brierley JB: The influence of mmaturity on hypoxic-ischemic brain damage in the rat. Ann Neural (1981)9: 131-141.
16. Meier C, Middelanis J, Wasielewski B, Neuhoff S, Roth-Haerer A. Gantert M, Dinse HR, Dermietzel R and Jensen A: Spastic Paresis After Perinatal Brain Damage in Rats Is Reduced by Human Cord Blood Mononuclear Cells. Pediatr Res (2006) 59: 244-249.
17. Pimentel-Coelho PM, Magalhaes ES, Lopes LM, deAzevedo LC Santiago MF and Mendez-Otero R: Human cord blood transplan-tation in a neonatal rat model of hypoxic-ischemic brain damage functional outcome related to neuroprotection in the striatum Stem Cells Dev (2010) 19: 351-358.
18. Yasuhara T, Hara K, Maki M, Xu L, Yu G, Ali MM, Masuda T. Yu SJ, Bae EK, Hayashi T, Matsukawa N, Kaneko Y, Kuzmin-Nichols N, Ellovitch S, Cruz EL, Klasko SK, Sanberg CD Sanberg PR and Borlongan CV: Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-schaemic rats with human umbilical cord blood grafts. J Cell Mol (2010) 14: 914-921.
19. Geissler M, Dinse HR, Neuhoff S, Kreikemeier K and Meier C Human umbilical cord blood cells restore brain damage induced changes in rat somatosensory cortex. PLoS One (2011) 6: e20194.
20. de Paula S, Vitola AS, Greggio S, de Paula D, Mello PB Lubianca JM, Xavier LL, Fiori HH and Dacosta JC: Hemispheric brain injury and behavioral deficits induced by severe neonatal hypoxia-ischemia in rats are not attenuated by intravenous admin-istration of human umbilical cord blood cells. Pediatr Res (2009) 65: 631-635.
21. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J and Chopp M: Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke (2001) 32: 2682-2688.
22. Vendrame M, Cassady J, NewcombJ, Butler T, Pennypacker KR Zigova T, Sanberg CD, Sanberg PR and Willing AE: Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke (2004) 35: 2390-2395.
23. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S. Hart C, Sanchez-Ramos J and Sanberg PR: Intravenous Versus Intrastriatal Cord Blood Administration in a Rodent Model of Stroke. J Neurosci Res (2003) 73: 296-307.
24. Vendrame M, Gemma C, Pennypacker KR, Bickford PC, Davis Sanberg C, Sanberg PR and Willing AE: Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neural (2006) 199: 191-200.
25. Borlongan CV, Hadman M, Sanberg CD and Sanberg PR: Central Nervous System Entry of Peripherally Injected Umbilical Cord Blood Cells Is Not Required for Neuroprotection. Stroke (2004) 35: 2385-2389.
26. Lim JY, Jeong CH, Jun JA, Kim SM, Ryu CH, Hou Y, Oh W. Chang JW and Jeun SS: Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral isch-emia. Stem Cell Res Ther (2011) 2: 38.
27. Bicknese AR, Goodwin HS, Quinn CO, Henderson VC, Chien SN and Wall DA: Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant (2002) 11(3): 261-264.
28. Neuhoff S, Moers J, Rieks M, Grunwald T, Jensen A, Dermietzel R and Meier C: Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Exp Hematol (2007) 35: 1119-1131.
29. Fan CG, Zhang QJ, Tang FW, Han ZB, Wang GS and Han ZC: Human umbilical cord blood cells express neurotrophic factors. Neurosci Lett (2005) 380: 322-325.
30. Newman MB, Willing AE, Manresa JJ, Sanberg CD and Sanberg PR: Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp Neural (2006) 199: 201-208.
31. Han BH and Holtzman DM: BDNF protects the neonatal brain from hypoxic-ischamic injury in vivo via the ERK pathway. J Neurosci (2000) 20: 5775-5781.
32. Yang JP, Liu HJ, Yang H and Feng PY: Therapeutic time window for the neuroprotective effects of NGF when administered after focal cerebral ischemia. Neural Sci (2011) 32: 433-441.
33. Rowe DD, Leonardo CC, Recio JA, Collier LA, Willing AE and Pennypacker KR: Human umbilical cord blood cells protect oligo-dendrocytes from brain ischemia through Akt signal transduction. J Biol Chem (2012) 287: 4177-4187.
34. Navaratna D, Guo S, Arai K and Lo EH: Mechanisms and targets for angiogenic therapy after stroke. Cell Adh Migr (2009) 3: 216-223.
35. Taguchi A, Soma T, TanakaH, Kanda T, NishimuraH, Yoshikawa H, Tsukamoto Y, Iso H, Fujimori Y, Stern DM, Naritomi H and Matsuyama T: Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest (2004) 114: 330-338.
36. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K. Nagatsuka K, Todo K, Mori K, Stern DM, Soma T and Naritom H: Circulating CD34-positive cells provide an index of cerebrovas-cular function. Circulation (2004) 109: 2972-2975.
37. Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K. Pietrzkowski Z, Kowalska MA, Gewirtz AM, Emerson SG and Ratajczak MZ: Numerous growth factors, cytokines, and chemok-ines are secreted by human CD34(+) cells, myeloblasts, erythro-blasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood (2001) 97: 3075-3085.
38. Ding DC, Shyu WC, Chiang MF, Lin SZ, Chang YC, Wang HJ Su CY and Li H: Enhancement of neuroplasticity through upregu-lation of betal-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis (2007) 27: 339-353.
39. Chung DJ, Choi CB, Lee SH, Kang EH, Lee JH, Hwang SH Han H, Lee JH, Choe BY, Lee SY and Kim HY: Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J Neurosci Res (2009) 87: 3554-3567.
40. Rosenkranz K, Kumbruch S, Tenbusch M, Marcus K, Marschner K. Dermietzel R and Meier C: Transplantation of human umbilical cord blood cells mediated beneficial effects on apoptosis, angiogenesis and neuronal survival after hypoxic-ischemic brain injury in rats. Cell Tissue Res (2012) 348: 429-438.
41. Zacharek A, Chen J, Cui X, Li A, Li Y, Roberts C, Feng Y, Gao Q and Chopp M: Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab (2007) 27: 1684-1691.
42. Lakhan SE, Kirchgessner A and Hofer M: Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med (2009) 7: 97.
43. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA and Hum PD: Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab (2006) 26: 654-665.
44. Xin J, Wainwright DA, Mesnard NA, Serpe CJ, Sanders VM and Jones KJ: IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection. Brain Behav Immun (2011) 25: 820-829.
45. Bae SH, KongTH, Lee HS, Kim KS, Hong KS, Chopp M, Kang MS and Moon J: Long-lasting paracrine effects of human cord blood cells (hUCBCs) on damaged neocortex in an animal model of cerebral palsy. Cell Transplant (2012).
46. Hagberg H, Gressens P and Mallard C: Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann Neural (2012) 71: 444-457.
47. Graeber MB, Li W and Rodriguez ML: Role of microglia in CNS inflammation. FEBS Lett (2011) 585: 3798-3805.
48. Zhou J, Huang WQ, Li C, Wu GY, Li YS, Wen SH, Lei WL and Liu KX: Intestinal ischemia/reperfusion enhances microglial activation and induces cerebral injury and memory dysfunction in rats. Crit Care Med (2012) 40: 2438-2448.
49. Biber K, Neumann H, Inoue K and Boddeke HW: Neuronal 'On' and 'Off signals control microglia. Trends Neurosci (2007) 30: 596-602.
50. Newcomb JD, Ajmo CT Jr, Sanberg CD, Sanberg PR, Pennypacker KR and Willing AE: Timing of cord blood treatment after experi-mental stroke determines therapeutic efficacy. Cell Transplant (2006) 15: 213-223.